MXCT vs PAYC · rev $38.6M vs P/E 33, rev $1.88B
MaxCyte Inc (MXCT) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
MXCT currently screens at market cap $124.3M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the MXCT and PAYC stock pages for the full models.
Not investment advice.